Literature DB >> 26972534

Roles for RNA-binding proteins in development and disease.

Amy E Brinegar1, Thomas A Cooper2.   

Abstract

RNA-binding protein activities are highly regulated through protein levels, intracellular localization, and post-translation modifications. During development, mRNA processing of specific gene sets is regulated through manipulation of functional RNA-binding protein activities. The impact of altered RNA-binding protein activities also affects human diseases in which there are either a gain-of-function or loss-of-function causes pathogenesis. We will discuss RNA-binding proteins and their normal developmental RNA metabolism and contrast how their function is disrupted in disease. This article is part of a Special Issue entitled SI:RNA Metabolism in Disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Development; Neurodegenerative disease; Protein aggregate; Protein mis-regulation; RNA processing; RNA-binding protein

Mesh:

Substances:

Year:  2016        PMID: 26972534      PMCID: PMC5003702          DOI: 10.1016/j.brainres.2016.02.050

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  79 in total

1.  FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP.

Authors:  Yong Yu; Robin Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

2.  GSK3β mediates muscle pathology in myotonic dystrophy.

Authors:  Karlie Jones; Christina Wei; Polina Iakova; Enrico Bugiardini; Christiane Schneider-Gold; Giovanni Meola; James Woodgett; James Killian; Nikolai A Timchenko; Lubov T Timchenko
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 5.  RNA-binding proteins with prion-like domains in ALS and FTLD-U.

Authors:  Aaron D Gitler; James Shorter
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

6.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

7.  Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.

Authors:  Eric T Wang; Neal A L Cody; Sonali Jog; Michela Biancolella; Thomas T Wang; Daniel J Treacy; Shujun Luo; Gary P Schroth; David E Housman; Sita Reddy; Eric Lécuyer; Christopher B Burge
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

8.  TDP-43 is a developmentally regulated protein essential for early embryonic development.

Authors:  Chantelle F Sephton; Shannon K Good; Stan Atkin; Colleen M Dewey; Paul Mayer; Joachim Herz; Gang Yu
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

9.  ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.

Authors:  Shuying Sun; Shuo-Chien Ling; Jinsong Qiu; Claudio P Albuquerque; Yu Zhou; Seiya Tokunaga; Hairi Li; Haiyan Qiu; Anh Bui; Gene W Yeo; Eric J Huang; Kevin Eggan; Huilin Zhou; Xiang-Dong Fu; Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Nat Commun       Date:  2015-01-27       Impact factor: 14.919

Review 10.  Functions of FUS/TLS from DNA repair to stress response: implications for ALS.

Authors:  Reddy Ranjith Kumar Sama; Catherine L Ward; Daryl A Bosco
Journal:  ASN Neuro       Date:  2014-06-01       Impact factor: 4.146

View more
  54 in total

1.  Dynein light chain DLC-1 promotes localization and function of the PUF protein FBF-2 in germline progenitor cells.

Authors:  Xiaobo Wang; Jenessa R Olson; Dominique Rasoloson; Mary Ellenbecker; Jessica Bailey; Ekaterina Voronina
Journal:  Development       Date:  2016-11-18       Impact factor: 6.868

2.  The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1.

Authors:  Nicola Cornella; Toma Tebaldi; Lisa Gasperini; Jarnail Singh; Richard A Padgett; Annalisa Rossi; Paolo Macchi
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

Review 3.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

4.  IGF2 mRNA binding protein 3 (IMP3) mediated regulation of transcriptome and translatome in glioma cells.

Authors:  Shruti Bhargava; Vikas Patil; Riyaz Ahmad Shah; Kumaravel Somasundaram
Journal:  Cancer Biol Ther       Date:  2017-12-19       Impact factor: 4.742

5.  SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.

Authors:  Sasank Vemuri; Rajneesh Srivastava; Quoseena Mir; Seyedsasan Hashemikhabir; X Charlie Dong; Sarath Chandra Janga
Journal:  Methods       Date:  2019-09-05       Impact factor: 3.608

6.  Lin28a Regulates Pathological Cardiac Hypertrophic Growth Through Pck2-Mediated Enhancement of Anabolic Synthesis.

Authors:  Hong Ma; Shuo Yu; Xiaojing Liu; Yingao Zhang; Thomas Fakadej; Ziqing Liu; Chaoying Yin; Weining Shen; Jason W Locasale; Joan M Taylor; Li Qian; Jiandong Liu
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

Review 7.  Practical considerations on performing and analyzing CLIP-seq experiments to identify transcriptomic-wide RNA-protein interactions.

Authors:  Xiaoli Chen; Sarah A Castro; Qiuying Liu; Wenqian Hu; Shaojie Zhang
Journal:  Methods       Date:  2018-12-06       Impact factor: 3.608

8.  DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.

Authors:  Qiong Wu; Jiali Ma; Wenying Meng; Pingping Hui
Journal:  Cancer Biol Ther       Date:  2019-10-08       Impact factor: 4.742

9.  A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.

Authors:  Ryan S Dhindsa; Anthony W Zoghbi; Daniel K Krizay; Chirag Vasavda; David B Goldstein
Journal:  Ann Neurol       Date:  2020-11-18       Impact factor: 10.422

10.  PTBP1 and PTBP2 Repress Nonconserved Cryptic Exons.

Authors:  Jonathan P Ling; Resham Chhabra; Jonathan D Merran; Paul M Schaughency; Sarah J Wheelan; Jeffry L Corden; Philip C Wong
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.